Home › Funds › Sava Infond d.o.o. › JNJ

Sava Infond d.o.o. position in JNJ

JOHNSON JOHNSON · Health Care

Sava Infond d.o.o. reported holding 34,930 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 0.54% of its reported portfolio and ranking #33 among its reported holdings. Sava Infond d.o.o. has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)34.93K sh
Reported value held$9.25M
Portfolio Weight0.54%
First reportedQ4 2024
Last changeAdd
Updated2026-10-28

Last updated: 2026-10-28 · Source: SEC EDGAR Form 13F-HR

How Sava Infond d.o.o.'s JNJ position evolved

Sava Infond d.o.o. first disclosed a stake in JNJ in Q4 2024 at 14,630 shares (US$2.1M). The position peaked in Q3 2026 at 34,930 shares, worth US$9.2M. Across 8 filings, Sava Infond d.o.o. increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 34,930 shares valued at US$9.2M — an increase of 18,025 shares quarter over quarter.. Notable position changes include a 107% increase in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 14.63K $2.12M New
Q1 2025 13.49K $2.24M Reduce
Q2 2025 14.32K $2.19M Add
Q3 2025 16.82K $3.12M Add
Q4 2025 18.02K $3.73M Add
Q1 2026 18.55K $4.53M Add
Q2 2026 16.91K $4.29M Reduce
Q3 2026 34.93K $9.25M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Sava Infond d.o.o. held JNJ?

Sava Infond d.o.o. has disclosed JNJ holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Sava Infond d.o.o.'s current position in JNJ?

As of Q3 2026, Sava Infond d.o.o. holds 34.93K shares of JNJ (JOHNSON JOHNSON), valued at $9.25M, representing 0.54% of its reported portfolio and ranking #33.

Has Sava Infond d.o.o. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Sava Infond d.o.o. increased its position in JNJ. The position peaked in Q3 2026 at 34.93K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.